 Your new post is loading...
 Your new post is loading...
|
Scooped by
Ed Rybicki
March 9, 2012 2:11 AM
|
ASM publications follow a simple set of guidelines. First, we believe strongly that good science should be published in its entirety after peer review. Accordingly, we require that all primary data be accessible, that DNA sequences be filed in GenBank, that structural coordinates be available, etc. Second, we also understand that science should do no harm. Accordingly, we require that all papers have vetted animal use and human subject protocols and that appropriate biosafety and biosecurity procedures have been followed. We also have set guidelines based on principles set forth by the National Academy of Sciences and the NSABB that attempt to deal with experiments in seven categories most likely to fall into “dual use research of concern” (2). These categories are “yellow lights” or “caution signals” that require extra attention to be sure that the work does not cause or have the potential to cause harm. A reasoned, careful analysis of a thorny problem. But again, letting the NSABB speak for the world.
|
Scooped by
Ed Rybicki
March 9, 2012 2:05 AM
|
A host of infectious and deadly diseases have hopped from animals to humans, and the other way. The delightfully sinister side of microbiology...B-)
|
Scooped by
Ed Rybicki
March 8, 2012 10:04 AM
|
Copyright 2011-3011 Alternative News Report, All Rights Reserved. See also http://funvax.wordpress.com/ The Pentagon presentation you are about to see took place in the Pentagon. It is date s... Light relief alert - except these people are SERIOUS!!
|
Scooped by
Ed Rybicki
March 8, 2012 7:00 AM
|
Researchers analysing the computer malware Duqu have hit a brick wall and are asking the programming community to help identify a mysterious code at the heart of the worm.
I tell you, more and more I feel that we need to incorporate computer viruses into our taxonomies
|
Rescooped by
Ed Rybicki
from The Microbiology Mine
March 8, 2012 6:23 AM
|
Map: Worldwide Confirmed Human Cases Updated. Click on image to enlarge. Click on title for postmark descriptions. Located on the right side-bar for future reference. Posted by Commonground at 6:44 AM ...
Via Elsevier Microbiol*
|
Scooped by
Ed Rybicki
March 8, 2012 2:33 AM
|
"...we intensively sampled two sympatric parrot populations from Mauritius over a period of 11 years and screened for the circovirus Beak and Feather Disease Virus. During the sampling period a severe outbreak of Psittacine Beak and Feather Disease, which is caused by Beak and Feather Disease Virus, occurred in Echo parakeets. Consequently, this dataset presents an ideal system to study the evolution of a pathogen in a natural population and to understand the adaptive changes that cause outbreaks." Reasonably good paper - and prescooped as a news item by both AJC and CU. A couple of problems with it, however: first, they say "Circoviruses are amongst the smallest and simplest of all viruses, but are relatively poorly characterised." - and neglect to cite a paper which DOES thoroughly characterise BFDV diversity. Varsani A, Regnard GL, Bragg R, Hitzeroth II, Rybicki EP. J Gen Virol. 2011 Apr;92(Pt 4):752-67. Second, they refer to a "replicase gene" or allele: it's Rep, guys, for replication associated protein - a rolling circle replication initiator, and NOT a replicase. Third - nah, that's enough.
|
Scooped by
Ed Rybicki
March 7, 2012 9:36 AM
|
New Scientist February 25 "If half the energy that went into seeing bioterrorists behind every Petri dish was expended on overcoming these obstacles, the squabble over publishing H5N1 research would become what it should be: purely academic."
|
Rescooped by
Ed Rybicki
from The Microbiology Mine
March 7, 2012 7:00 AM
|
A mobile phone app could help monitor the way infectious diseases turn into epidemics, Cambridge researchers say. ...
Via Elsevier Microbiol*
|
Scooped by
Ed Rybicki
March 7, 2012 6:46 AM
|
In 2006, a new retrovirus was isolated from prostate cancer patient tissue. Named xenotropic murine leukemia virus-related virus (XMRV), this was potentially the third class of retrovirus to be pathogenic in humans. XMRV made a more dramatic impact on the wider scientific community, and indeed the media, in 2009 when it was reported to be present in a remarkably high proportion of patients with chronic fatigue syndrome as well as a significant, albeit smaller, proportion of healthy controls. The apparent strong link to disease and the fear of a previously unknown retrovirus circulating in the general population lead to a surge in XMRV research. Subsequent studies failed to find an association of XMRV with disease and, in most cases, failed to find the virus in human samples. In 2011, the case against XMRV and human disease strengthened, ending with several decisive publications revealing the origin of the virus and demonstrating contamination of samples. In this review, we outline the passage of research on XMRV and its potential association with disease from its isolation to the present day, where we find ourselves at the end of a turbulent story. Good review on a very contentious topic
|
Scooped by
Ed Rybicki
March 7, 2012 6:39 AM
|
Inovio Pharmaceuticals (AMEX:INO) said Monday its SynCon vaccine induced a positive T-Cell immune response in mice with diseases caused by the human papillomavirus (HPV) types 6 and 11, broadening the company's reach with the synthetic vaccine.
|
Scooped by
Ed Rybicki
March 7, 2012 6:37 AM
|
Study results presented today by Mark Cotton, M.D., Ph.D., of Stellenbosch University in South Africa, showed that infants could safely stop ART after 1 to 2 years and continue to fare significantly better than those infants in whom the initiation of therapy was delayed until signs of illness or a weakened immune system appeared. Importantly, very few infants who received immediate ART had significant disease progression or died after treatment was stopped. News from our neighbours: good one, Mark C! Picture courtesy Russell Kightley Media
|
Scooped by
Ed Rybicki
March 7, 2012 6:25 AM
|
While research on the lab-altered H5N1 virus that can be transmitted between mammals in laboratories is put on hold, scientists are debating how to balance biosecurity with the need for research that could help thwart a pandemic. The issue: What biosafety containment level (BSL) should be used for the viruses? The levels range from BSL-1 to BSL-4, which are designated in ascending order by degree of protection provided to lab personnel, the environment and the community. Biosafety levels apply to labs dealing with infectious microbes. Currently, studies with these viruses, which were engineered to spread via respiratory droplets between ferrets, are being done at BSL-3 or higher facilities. However, Canada has already moved to institute the highest level of biosafety containment research for these viruses.... Meanwhile, farmers in Indonesia and Vietnam continue to breathe 'em in....
|
Scooped by
Ed Rybicki
March 7, 2012 6:07 AM
|
Medicago Inc. has entered into a strategic alliance with Mitsubishi Tanabe Pharma Corporation to develop and commercialize at least three new vaccines together. Under this first agreement to develop a Rotavirus Like Particle (RLP) vaccine target, MTPC will have the option to license the RLP vaccine target and assume global development, regulatory and commercialization responsibilities while Medicago will be eligible to receive up to a total of C$33 million (approximately US$33 million) in upfront and milestone payments as well as royalties on future sales of the RLP product. Going green - the right thing to do!
|
|
Scooped by
Ed Rybicki
March 9, 2012 2:08 AM
|
We conclude that the early control of HIV-1 replication by immunodominant CD8+ T cell responses may be substantially influenced by rapid, low frequency viral adaptations not detected by conventional sequencing approaches, which warrants further investigation. These data support the critical need for vaccine-induced CD8+ T cell responses to target more highly constrained regions of the virus in order to ensure the maintenance of immunodominant CD8 responses and the sustained decline of early viremia. So: it's the luck of the draw, then. And T-cell-stimulating vaccines are the way to go?
|
Scooped by
Ed Rybicki
March 8, 2012 10:31 AM
|
Researchers say boys should be vaccinated to stem rise in HPV-related disease. Amen!
|
Scooped by
Ed Rybicki
March 8, 2012 7:04 AM
|
Defeat the virus strategically.(Chainvirus: Defeat the virus strategically.)...
Until I get my iPad offering going....
|
Scooped by
Ed Rybicki
March 8, 2012 6:59 AM
|
THE Department of Health has received an expert report on a possible link between the sleeping disorder narcolepsy and the human swine flu vaccine Pandemrix.
Just when I'd convinced everyone around me to get vaccinated...!
|
Scooped by
Ed Rybicki
March 8, 2012 2:38 AM
|
"...the E1-defective HPV16 genome became established in human keratinocytes only as episomes in the presence of exogenous E1 expression. Once established, it could replicate with the same efficiency as the wild-type genome, even after the exogenous E1 was removed. However, upon calcium-induced keratinocyte differentiation, once again amplification was dependent on exogenous E1. These results demonstrate that the E1 protein is dispensable for maintenance replication but not for initial and productive replication of HPV16." Always a good idea to check whether or not your virus is actually susceptible when you think it is.... Image by Russell Kightley Media
|
Scooped by
Ed Rybicki
March 7, 2012 3:57 PM
|
At least 50 people have died of rabies in the recent weeks in a reported outbreak in the south west district of Indonesia's Maluku province, local officials said on Monday [5 Mar 2012]. "Rabies has killed at least 50 people, and hundreds of others have been infected [that is, exposed to the risk of the disease]," Bernabas Orno said, adding that the outbreak has been reported to Maluku governor Karel Albert Ralahalu. The deadly virus has hit this remote province hard in recent weeks. The rabies virus is spread through contact with infected animals, who carry the virus in their saliva. Those bitten by an infected animal can avoid contracting the deadly disease if they clean the wound and receive a rabies vaccination within hours of contact. But rabies vaccine supplies in the remote Southwest Maluku district have run out, Barnabas said. No hospitals in the district have the vaccine, and efforts to control the spread of the virus have failed to make an impact, he added. "We are badly in need of the provincial government's help," Barnabas said. Without help, Barnabas feared that the rabies epidemic in the Southwest Maluku district would only get worse.
|
Rescooped by
Ed Rybicki
from The Microbiology Mine
March 7, 2012 7:01 AM
|
In the invisible, parallel world of Earth's they kill half the bacteria in the ocean every day, and invade a microbe host 10 trillion times a second around the world. I like telling people that if you put all the viruses in the world's oceans end to end, it would stretch for 160 million light years - further than the next galactic CLUSTER, let alone galaxy.
Via Elsevier Microbiol*
|
Rescooped by
Ed Rybicki
from The Microbiology Mine
March 7, 2012 6:59 AM
|
|
Scooped by
Ed Rybicki
March 7, 2012 6:41 AM
|
Psoriasis is an autoimmune disease—the immune system mistakenly attacks its own body, causing red, itchy, scaly patches on the skin. But there may be a hidden upside. People with psoriasis are more likely to have gene variants that protect them against the effects of HIV-1. Researchers had noticed that some psoriasis patients had the same gene variants as people known as "HIV-1 controllers." Such people have HIV-1, but they naturally maintain low levels of the virus and generally do not develop any obvious symptoms of AIDS. Interesting trade-off...!
|
Scooped by
Ed Rybicki
March 7, 2012 6:38 AM
|
msnbc.comMost Android anti-virus products don't work, tests findmsnbc.comAn independent IT security firm deemed nearly two-thirds of Android anti-virus scanning software "not yet suitable for use as reliable products." Out of 41 different Android... Yet more reasons to have an iPad...B-)
|
Scooped by
Ed Rybicki
March 7, 2012 6:27 AM
|
M2 protein of influenza A viruses is a tetrameric transmembrane proton channel, which has essential functions both early and late in the virus infectious cycle. Previous studies of proton transport by M2 have been limited to measurements outside the context of the virus particle. We have developed an in vitro fluorescence-based assay to monitor internal acidification of individual virions triggered to undergo membrane fusion. We show that rimantadine, an inhibitor of M2 proton conductance, blocks the acidification-dependent dissipation of fluorescence from a pH-sensitive virus-content probe. Fusion-pore formation usually follows internal acidification but does not require it. The rate of internal virion acidification increases with external proton concentration and saturates with a pKm of ~4.7. The rate of proton transport through a single, fully protonated M2 channel is approximately 100 to 400 protons per second. The saturating proton-concentration dependence and the low rate of internal virion acidification derived from authentic virions support a transporter model for the mechanism of proton transfer.
|
Scooped by
Ed Rybicki
March 7, 2012 6:21 AM
|
(Reuters) - Two more patients in a 10-patient segment of a mid-stage trial testing Gilead Sciences Inc's experimental hepatitis C drug GS-7977 had the virus return within four weeks of treatment, researchers...
|